ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $58,942,000 | +150.4% | 1,272,213 | +31.8% | 0.15% | +149.2% |
| Q1 2019 | $23,537,000 | +214.9% | 965,413 | +84.1% | 0.06% | +195.0% |
| Q4 2018 | $7,474,000 | -27.3% | 524,513 | -22.5% | 0.02% | -20.0% |
| Q3 2018 | $10,284,000 | -43.2% | 676,600 | -37.3% | 0.02% | -49.0% |
| Q2 2018 | $18,118,000 | -15.7% | 1,079,713 | -18.0% | 0.05% | -15.5% |
| Q1 2018 | $21,482,000 | +37.7% | 1,316,313 | +8.0% | 0.06% | +38.1% |
| Q4 2017 | $15,606,000 | -8.9% | 1,219,240 | -12.4% | 0.04% | -14.3% |
| Q3 2017 | $17,123,000 | +727.2% | 1,392,093 | +462.9% | 0.05% | +600.0% |
| Q2 2017 | $2,070,000 | -44.2% | 247,300 | -40.4% | 0.01% | -41.7% |
| Q1 2017 | $3,712,000 | +195.3% | 415,249 | +190.4% | 0.01% | +140.0% |
| Q4 2016 | $1,257,000 | -25.6% | 143,013 | -42.9% | 0.01% | -28.6% |
| Q3 2016 | $1,690,000 | +93.1% | 250,413 | +1.9% | 0.01% | +75.0% |
| Q2 2016 | $875,000 | -18.8% | 245,713 | -32.8% | 0.00% | -33.3% |
| Q1 2016 | $1,078,000 | -31.4% | 365,413 | -1.9% | 0.01% | -33.3% |
| Q4 2015 | $1,571,000 | -16.2% | 372,313 | -4.9% | 0.01% | -25.0% |
| Q3 2015 | $1,874,000 | -53.1% | 391,513 | -29.4% | 0.01% | -61.3% |
| Q2 2015 | $3,999,000 | +179.5% | 554,647 | +185.7% | 0.03% | +181.8% |
| Q1 2015 | $1,431,000 | +306.5% | 194,113 | +160.5% | 0.01% | +266.7% |
| Q4 2014 | $352,000 | +130.1% | 74,513 | +130.6% | 0.00% | +200.0% |
| Q1 2014 | $153,000 | -37.8% | 32,313 | -33.7% | 0.00% | -50.0% |
| Q4 2013 | $246,000 | – | 48,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |